| JYHB2001446 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | Supplementary Application | 2020-08-21 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production | Filed | 2020-09-01 | view |
| JYHB2101627 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | Supplementary Application | 2022-01-05 | | Laboratoire Glaxosmithkline;Glaxo Wellcome Production | | | view |
| CYHS1700711 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs(4) | Generic Drug | 2018-05-30 | 长风药业股份有限公司 | CF PharmTech Inc | In Review | 2018-05-28 | view |
| JYHB2101420 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | Supplementary Application | 2021-09-16 | | Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production | | | view |
| CYHS2500587 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs(4) | Generic Drug | 2025-02-07 | | CF PharmTech Inc | | | view |
| JYHZ1900157 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | License Renew | 2019-07-01 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production | Certificate Issued | 2019-11-25 | view |
| JYHB2200293 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | Supplementary Application | 2022-06-14 | | Laboratoire Glaxosmithkline;Glaxo Wellcome Production | | | view |
| JYHB2101629 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | Supplementary Application | 2021-12-30 | | Laboratoire Glaxosmithkline;Glaxo Wellcome Production | | | view |
| JYHZ2300408 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | License Renew | 2023-10-31 | | GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production | | | view |
| JYHB2101628 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | Supplementary Application | 2022-01-05 | | Laboratoire Glaxosmithkline;Glaxo Wellcome Production | | | view |
| JYHB2101419 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | Supplementary Application | 2021-09-16 | | Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production | | | view |
| JYHZ2300409 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | License Renew | 2023-10-31 | | GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production | | | view |
| JYHZ1900158 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | License Renew | 2019-07-01 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production | Certificate Issued | 2019-11-25 | view |
| JYHB2100101 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | Supplementary Application | 2021-01-29 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production | In Review | 2021-01-28 | view |
| JYHZ2300410 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | License Renew | 2023-10-31 | | GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production | | | view |
| JYHZ1800391 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | License Renew | 2018-11-30 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production | Certificate Issued | 2019-05-24 | view |
| JYHB2200292 | 沙美特罗替卡松吸入气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | Supplementary Application | 2022-06-14 | | Laboratoire Glaxosmithkline;Glaxo Wellcome Production | | | view |
| JYHB1601402 | 沙美特罗替卡松气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | Supplementary Application | 2016-11-16 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production | Certificate Issued | 2017-06-06 | view |
| J0300958 | 沙美特罗替卡松气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | Supplementary Application | 2003-10-30 | GlaxoSmithKline Australia Ltd | Glaxo Smithkline Australia Pty Ltd;GlaxoSmithKline (China) Investment Co Ltd | Certificate Completed-Pending Issued | 2004-04-16 | view |
| JYHB1301726 | 沙美特罗替卡松气雾剂 | fluticasone propionate;salmeterol xinafoate | Aerosol | Chemical Drugs | Supplementary Application | 2014-01-13 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production | Certificate Issued | 2014-05-22 | view |
